**Comes with Bacteriostatic Water, Syringes, Alcohol Swab-Pads and Dosing Protocol**
 
CJC-1295 + DAC (Drug Affinity Complex) is a synthetic research peptide that functions as an analog of Growth Hormone-Releasing Hormone (GHRH). It stimulates the pituitary gland to produce and release growth hormone (GH) and insulin-like growth factor 1 (IGF-1). It is commonly combined with Ipamorelin for stronger synergistic effect.
 
Mechanism of action
CJC-1295 works by mimicking the natural hormone GHRH and binding to GHRH receptors in the anterior pituitary gland. This triggers a release of growth hormone from the pituitary gland into the bloodstream. 
There are two main forms of CJC-1295:
 
CJC-1295 with DAC (Drug Affinity Complex): This version has a significantly extended half-life (around 6-8 days) due to its ability to bind with albumin in the bloodstream. This allows for sustained GH release and less frequent injections, typically once or twice per week.
 
Potential benefits
Muscle Growth and Repair: CJC-1295 may promote muscle growth by increasing protein synthesis and IGF-1 levels. It also aids in tissue repair and recovery from injuries.
Fat Loss: By stimulating the breakdown of fat cells and boosting metabolism, CJC-1295 can be an effective tool for fat loss and body composition improvement.
Improved Sleep Quality: CJC-1295 may enhance sleep quality by promoting deeper sleep stages, which is crucial for overall health and recovery.
Anti-Aging Effects: Elevated growth hormone levels can lead to improvements in skin elasticity, reduce wrinkles, strengthen hair and nails, and may contribute to a more youthful appearance and increased energy levels.
Enhanced Immune Function: CJC-1295 may enhance the body's immune function by increasing the production of white blood cells, which can help fight infections and illnesses.
Improved Cognitive Function: Increased growth hormone levels may support cognitive functions like memory retention, focus, and concentration.
Strengthens Cardiovascular System: May lead to higher metabolism and less body fat, contributing to a healthier cardiovascular system.
Improved Bone Density: CJC-1295 may promote bone formation by increasing osteoblast activity. 
Administration
CJC-1295 is typically administered via subcutaneous injection. 
 
Combination with Ipamorelin
CJC-1295 is often combined with Ipamorelin. Ipamorelin is a growth hormone-releasing peptide (GHRP) that works differently than CJC-1295 but also stimulates GH release. This combination creates a synergistic effect, resulting in higher and more sustained GH levels, mimicking the body's natural GH pulse and potentially amplifying the benefits compared to using either peptide alone.